New developments in the pathology of skull base tumors

Virchows Archiv

Volumn 438, Issue 4, 2001, Pages 321-335

  Radner, H ^a   Katenkamp, D ^b   Reifenberger, G ^a   Deckert, M ^a   Pietsch, T ^a   Wiestler, O D ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chordoidchondroid; Chordoma; Glioma; Immunohistochemistry; Meningioma; Molecular genetics; Pituitary adenoma; Rhabdoid; Sarcoma; Skull base

Indexed keywords

ANAPLASTIC CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CHONDROSARCOMA; CHORDOMA; CLEAR CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; ESTHESIONEUROBLASTOMA; FIBROMATOSIS; GLIOBLASTOMA; HEMANGIOBLASTOMA; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MENINGIOMA; PATHOLOGY; PRIORITY JOURNAL; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SARCOMA; SKULL BASE TUMOR;

CHORDOMA; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM STAGING; NEURILEMMOMA; SKULL BASE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035075681     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100395     Document Type: Review

References (98)

1. Secretory meningioma. A distinct subtype of meningioma
2. Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction
3. Immunohistochemical detection of p53 protein in rhabdomyosarcoma: Association with clinicopathological features and outcome
4. Identification of the t(X;18) as a diagnostic tool in the differential diagnosis of synovial sarcomas versus peripheral nerve sheath tumors
5. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
6. Immunohistochemical detection of female sex hormone receptors in meningiomas: Correlation with clinical and histological features
7. Third ventricular chordoid glioma: A distinct clinicopathologic entity
8. Does chondroid chordoma exist?
9. Cytogenetic investigation of chordomas of the skull
10. Tissue polypeptide antigen staining of the chordoma and notochordal remnants
11. Tumors of the central nervous system
12. Solitary fibrous tumor of the meninges: A lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study
13. Experience in charged particle irradiation of tumors of the skull base: 1977-1992
14. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma
15. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma
16. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction
17. Meta-analysis of progestin and estrogen receptors in human meningiomas
18. Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients
19. Primary melanocytomas of the spinal cord: A report of seven cases
20. CD99 reactivity in mesenchymal chondrosarcoma
21. S-100 protein reactivity in synovial sarcomas: A potentially frequent diagnostic pitfall. Immunohistochemical analysis of 100 cases
22. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas
23. Chordomas and cartilaginous tumors at the skull base
24. Recurrent t(12;19)(q13;q13.3) in intracranial and extracranial hemangiopericytoma
25. Cytogenetic studies of four hemangiopericytomas
26. Overexpression of bcl-2 protein in synovial sarcoma: A comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization
27. Progesterone and estrogen receptors in meningiomas: Prognostic considerations
28. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors
29. Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: Can immunohistochemistry resolve the controversy?
30. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients
31. Exon scanning for mutation of the NF2 gene in schwannomas
32. Histological subtypes and prognostic problems in meningiomas
33. Meningeal melanocytoma. Report of a case and review of the literature
34. NF2 gene analysis distinguishes hemangiopericytoma from meningioma
35. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma
36. Primary malignant fibrous histiocytoma of the maxilla and mandible. Clinical aspects and pathology - 2 Case reports
37. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor
38. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma
39. "Chordoid" meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases
40. Rhabdoid transformation of tumor cells in meningiomas: A histologic indication of increased proliferative activity: Report of four cases
41. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas
42. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours
43. Unusual dural and skull-based mesenchymal neoplasms: A report of four cases
44. Myxoid synovial sarcoma: An underappreciated morphologic subset
45. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: A reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma
46. Papillary meningioma: A malignant variant of meningioma
47. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour
48. Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance
49. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization
50. Rhabdomyosarcoma of head and neck - An analysis of 24 cases
51. The histological spectrum of hemangiopericytoma: Application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis
52. Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas
53. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications
54. Malignant fibrous histiocytoma of the temporal bone with endocranial extension
55. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - An Intergroup Rhabdomyosarcoma Study
56. Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas
57. Biology and therapy of pediatric rhabdomyosarcoma
58. Papillary meningioma. Clinicopathologic study of seven cases and review of the literature
59. The immunophenotypic spectrum of meningeal hemangiopericytoma: A comparison with fibrous meningioma and solitary fibrous tumor of meninges
60. Meningioma grading: An analysis of histologic parameters
61. "Rhabdoid" meningioma: An aggressive variant
62. "Malignancy" in meningiomas: A clinicopathologic study of 116 patients, with grading implications
63. Malignant fibrous histiocytoma of the stomach. A case report with a review of the literature
64. Rhabdomyosarcoma of the ear in childhood. A report from the Intergroup Rhabdomyosarcoma Study-I
65. Low-grade myxoid chondrosarcoma of the temporal bone: Differential diagnosis and report of two cases
66. Chordoid glioma of the third ventricle: Immunohistochemical and molecular genetic characterization of a novel tumor entity
67. Nevomelanocytic proliferations in the central nervous system of children
68. Chondroid chordoma - A variant of chordoma. A morphologic and immunohistochemical study
69. Mesenchymal chondrosarcoma: A clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system
70. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
71. Molecular differential pathology of rhabdomyosarcoma
72. Cranial and cervical chordomas. A differential diagnostic problem
73. Extraskeletal mesenchymal chondrosarcoma
74. Chromosome translocations in sarcomas and the analysis of paraffin-embedded material
75. Orofacial synovial sarcoma: A clinicopathologic study of 11 new cases and review of the literature
76. Mesenchymal chondrosarcoma in anterior skull base: Case report
77. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation
78. Immunohistochemical demonstration of glycoprotein p30/32MIC2 (CD99) in synovial sarcoma
79. Involvement of chromosome X in primary cytogenetic change in human neoplasia: Nonrandom translocation in synovial sarcoma
80. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas
81. Drop metastases in a patient with a chondroid chordoma of the clivus
82. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma
83. Cytogenetic studies in malignant fibrous histiocytoma
84. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood
85. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
86. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma
87. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit
88. Myo-D1 as a specific marker for rhabdomyosarcoma: A study including rhabdomyosarcoma, Ewing's sarcoma/PNET, leiomyosarcoma and alveolar soft part sarcoma
89. Cytological and cytogenetical studies on human meningioma
90. Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique
91. The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma
92. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma